European Commission logo
italiano italiano
CORDIS - Risultati della ricerca dell’UE
CORDIS

A Body Scan for Cancer Detection using Quantum Technology

Descrizione del progetto

Innovativo rilevamento del carcinoma mammario basato su tecnologie ottiche e quantistiche

Il cancro è la seconda principale causa di morte a livello globale e il carcinoma mammario è tra i tipi più comuni. Il progetto CANCER SCAN, finanziato dall’UE, sta sviluppando un metodo innovativo di rilevamento del carcinoma mammario basato su tecnologie ottiche e quantistiche, volto a migliorare la diagnosi con un’esposizione minima alle radiazioni. Il concetto innovativo implica l’utilizzo non invasivo della luce e la trasmissione e il rilevamento unificati di fotoni nello spazio multidimensionale, il che consente allo scanner di rilevare i tumori contemporaneamente in tutte le parti del corpo con un rischio minimo di radiazione. Data la prevalenza della malattia, l’importanza di questo progetto pilota, incentrato sul rilevamento precoce del carcinoma mammario come sviluppo di un metodo di diagnosi migliorato e affidabile, è fondamentale.

Obiettivo

We propose to develop a radically new unified technological concept of biomedical detection utilizing front line new ideas in quantum optics and quantum mechanics. The new concept will be based on unified transmission and detection of photons in a three dimensional space of orbital angular momentum, entanglement and hyper-spectral characteristics (OES). These will enable a revolutionary scanner capable of detecting cancer not only in a specified organ but in various parts of the body at once, even from remote locations, and with no radiation risk whatsoever. Our pilot project will be focused on the early detection of breast cancer. Mammography, as the state of the art method for breast cancer screening, is limited in its sensitivity especially in younger women and/or women with dense breasts, and has been found to be problematic in women with genetic mutations. Thus the development of an improved and more reliable detection method is of paramount importance. A novel detection algorithm will be developed based on clinical trials in breast cancer patients, using the unified transmission and detection theory. We chose to verify our concept in the area of breast cancer due to its prevalence and the condition that feeds our concept (large amount of tissue without bone). In the long term this approach can be adapted to other areas of bio-medical diagnostics leading to total mass screening. The concept is based on non invasive utilization of light and its ramifications are numerous.
In the proposed project, the endeavor will be both theoretical and experimental including derivation of a mathematical
model and development of an experimental bio-compatible test-bed for cancer detection with minimal false positives.
Our joint knowledge places the project at the cutting edge of science and technology developing a novel technology with the
long-term vision of integrating quantum science in medical applications.

Invito a presentare proposte

H2020-FETOPEN-2018-2020

Vedi altri progetti per questo bando

Bando secondario

H2020-FETOPEN-2018-2019-2020-01

Meccanismo di finanziamento

RIA - Research and Innovation action

Coordinatore

BEN-GURION UNIVERSITY OF THE NEGEV
Contribution nette de l'UE
€ 1 297 300,00
Indirizzo
.
84105 Beer Sheva
Israele

Mostra sulla mappa

Tipo di attività
Higher or Secondary Education Establishments
Collegamenti
Costo totale
€ 1 297 300,00

Partecipanti (3)